Cargando…

ADP receptor P2Y12 is the capstone of the cross-talk between Ca(2+) mobilization pathways dependent on Ca(2+) ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets

BACKGROUND: Blood platelet Ca(2+) stores are regulated by 2 Ca(2+)-ATPases (SERCA2b and SERCA3). On thrombin stimulation, nicotinic acid adenosine dinucleotide phosphate mobilizes SERCA3-dependent stores, inducing early adenosine 5‘-diphosphate (ADP) secretion, potentiating later SERCA2b-dependent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Miao, Hechler, Béatrice, Adam, Frédéric, Gachet, Christian, Eckly, Anita, Kauskot, Alexandre, Denis, Cécile V., Bryckaert, Marijke, Bobe, Régis, Rosa, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031336/
https://www.ncbi.nlm.nih.gov/pubmed/36970741
http://dx.doi.org/10.1016/j.rpth.2022.100004
Descripción
Sumario:BACKGROUND: Blood platelet Ca(2+) stores are regulated by 2 Ca(2+)-ATPases (SERCA2b and SERCA3). On thrombin stimulation, nicotinic acid adenosine dinucleotide phosphate mobilizes SERCA3-dependent stores, inducing early adenosine 5‘-diphosphate (ADP) secretion, potentiating later SERCA2b-dependent secretion. OBJECTIVES: The aim of this study was to identify which ADP P2 purinergic receptor (P2Y1 and/or P2Y12) is(are) involved in the amplification of platelet secretion dependent on the SERCA3-dependent Ca(2+) mobilization pathway (SERCA3 stores mobilization) as triggered by low concentration of thrombin. METHODS: The study used the pharmacologic antagonists MRS2719 and AR-C69931MX, of the P2Y1 and P2Y12, respectively, as well as Serca3(-/-) mice and mice exhibiting platelet lineage-specific inactivation of the P2Y1 or P2Y12 genes. RESULTS: We found that in mouse platelets, pharmacological blockade or gene inactivation of P2Y12 but not of P2Y1 led to a marked inhibition of ADP secretion after platelet stimulation with low concentration of thrombin. Likewise, in human platelets, pharmacological inhibition of P2Y12 but not of P2Y1 alters amplification of thrombin-elicited secretion through SERCA2b stores mobilization. Finally, we show that early SERCA3 stores secretion of ADP is a dense granule secretion, based on parallel adenosine triphosphate and serotonin early secretion. Furthermore, early secretion involves a single granule, based on the amount of adenosine triphosphate released. CONCLUSION: Altogether, these results show that at low concentrations of thrombin, SERCA3- and SERCA2b-dependent Ca(2+) mobilization pathways cross-talk via ADP and activation of the P2Y12, and not the P2Y1 ADP receptor. The relevance in hemostasis of the coupling of the SERCA3 and the SERCA2b pathways is reviewed.